Product logo
  • Home
  • Sign Up
Product logo

Kilitch Drugs (India) Ltd

News

Switch to
tickertape logoView more
    Home
    Sign Up

    Kilitch Drugs (India) Ltd

    KILITCH
    168.652.20 (-1.29%)
    Investment Checklist
    BasicPro

    Intrinsic Value
    Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

    Current price is more than the intrinsic value

    ROE vs FD rates
    Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

    Stock has not been able to generate better return on equity than bank FD

    Dividend Returns
    A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

    Stock doesn't offer attractive dividend returns

    Entry Point
    High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

    Good time to consider, as stock is not in overbought zone

    No Red Flags
    ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks

    Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

    Loading...
    Go pro! Unlock deeper insights
    Get your Zerodha accountOpen Now
    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    662

    News & Opinions

    662
    Articles & Videos
    News Thumbnail

    Kilitch Drugs Standalone March 2022 Net Sales at Rs 32.03 crore, up 51.49% Y-o-Y

    2 months ago•Moneycontrol

    News Thumbnail

    Kilitch Drugs commences Rs100 crore new facility expansion plan

    5 months ago•India Infoline

    News Thumbnail

    Kilitch Drugs (India) reports standalone net profit of Rs 2.89 crore in the June 2021 quarter

    1 year ago•Business Standard

    News Thumbnail

    Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant; Stock surges 5%

    1 year ago•India Infoline

    News Thumbnail

    Kilitch Drugs (India) reports consolidated net profit of Rs 0.71 crore in the March 2021 quarter

    1 year ago•Business Standard

    News Thumbnail

    Buzzing Stocks | Bharti Airtel, RIL, Railtel, Bank Of Maharashtra, Equitas Holdings, Tata Chemicals, Hindustan Aeronautics

    1 year ago•Moneycontrol

    News Thumbnail

    Board of Kilitch Drugs (India) approves change in CFO and company secretary

    1 year ago•Business Standard

    © Powered byTickertape.ViewKILITCHon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019